Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1/PHASE2
200 participants
INTERVENTIONAL
2020-07-14
2021-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy of Oral Antiseptics Against COVID-19
NCT05214196
Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients
NCT04410159
Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19
NCT04371965
A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients
NCT04341688
COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients
NCT04364802
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Iodine Complex (Capsule form)
Iodine Complex) capsule (200mg) will be given three times a day
Iodine Complex
Iodine Complex capsule (200mg) will be given three times a day
Iodine Complex (Syrup form)
Iodine Complex syrup form (40ml) will be given three times a day
Iodine Complex
Iodine Complex syrup form (40ml) will be given three times a day
Standard Care Alone
Placebo as empty capsule. Treatment will be given for all 4 arms will be receiving standard care as per version 3.0 of clinical management guidelines for COVID-19 established by the Ministry of National Health Services of Pakistan COVID-19 guidelines of the study setting.
Placebo
Empty capsule will be given as placebo
Iodine Complex (Nasal Spray)
Iodine complex throat spray of 2 puffs three times a day.
Idoine Complex
Iodine Complex spray form 2 puffs will be given three times a day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Iodine Complex
Iodine Complex capsule (200mg) will be given three times a day
Iodine Complex
Iodine Complex syrup form (40ml) will be given three times a day
Placebo
Empty capsule will be given as placebo
Idoine Complex
Iodine Complex spray form 2 puffs will be given three times a day
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Any co-morbidity other than hypertension and dietetics
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohaib Ashraf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sohaib Ashraf
Post-Graduate Resident Cardiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Muhammad Ashraf, PhD
Role: STUDY_CHAIR
University of Veterinary & Animal Sciences, Pakistan
Shoaib Ashraf, PhD
Role: STUDY_DIRECTOR
Harvard University, Massachusetts General Hospital, Boston, USA
Moneeb Ashraf, MBBS
Role: PRINCIPAL_INVESTIGATOR
Mayo Hospital, Pakistan
Sohaib Ashraf, MBBS
Role: PRINCIPAL_INVESTIGATOR
Shaikh Zayed Medical Complex, Pakistan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shaikh Zayed Hospital
Lahore, , Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Ashraf S, Ashraf S, Ashraf M, Imran MA, Kalsoom L, Siddiqui UN, Farooq I, Ghufran M, Khokhar RA, Akram MK, Shahid I, Sohaib Ur Rehman M, Akmal R, Tahir A, Zahid A, Ashraf S, Rafique S, Matti N, Nadeem MF, Humayun A, Malik A, Saboor QA, Ahmad A, Ashraf M, Izhar M. A quadruple blinded placebo controlled randomised trial to evaluate the effectiveness of an Iodine complex for patients with mild to moderate COVID-19 in Pakistan (I-COVID-PK): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Feb 10;22(1):127. doi: 10.1186/s13063-021-05081-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SZMC/IRB/Internal/216/2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.